Volitionrx (VNRX) Payables (2019 - 2025)
Historic Payables for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $4.6 million.
- Volitionrx's Payables rose 8685.87% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 8685.87%. This contributed to the annual value of $2.8 million for FY2024, which is 1386.08% down from last year.
- Latest data reveals that Volitionrx reported Payables of $4.6 million as of Q3 2025, which was up 8685.87% from $2.5 million recorded in Q2 2025.
- In the past 5 years, Volitionrx's Payables ranged from a high of $4.6 million in Q3 2025 and a low of $1.1 million during Q2 2021
- Its 5-year average for Payables is $2.7 million, with a median of $2.9 million in 2023.
- Per our database at Business Quant, Volitionrx's Payables skyrocketed by 14024.35% in 2022 and then tumbled by 2480.46% in 2025.
- Quarter analysis of 5 years shows Volitionrx's Payables stood at $1.5 million in 2021, then skyrocketed by 97.28% to $3.0 million in 2022, then increased by 5.53% to $3.2 million in 2023, then fell by 13.86% to $2.8 million in 2024, then surged by 67.87% to $4.6 million in 2025.
- Its last three reported values are $4.6 million in Q3 2025, $2.5 million for Q2 2025, and $3.0 million during Q1 2025.